Biological Mimetics, Inc.
Frederick, MD
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
- Plano, TX HEQ7AW5KUFM9
-
- SAM.gov registration date
- Physical address
- 124 Byte Dr, Frederick, MD 21702, USA
- Website
- biologicalmimetics.com
- Founded
- 1996
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $1,498,641 |
| FY2024 | $0 |
| FY2023 | $299,817 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Biological Mimetics, Inc. is a biotechnology firm located in Frederick, Maryland, specializing in developing advanced diagnostic technologies, vaccines, and innovative solutions for infectious diseases and public health challenges. Registered in SAM.gov since 2003, the company operates as a for-profit corporate entity with a focus on research and development in emerging medical technologies. The firm actively participates in federal contract and grant programs, particularly through Small Business Innovation Research (SBIR) mechanisms, demonstrating expertise in developing specialized diagnostic and vaccine technologies for challenging medical conditions.
Through federal contract awards, Biological Mimetics, Inc. has primarily engaged in SBIR-funded projects with the National Institute of Allergy and Infectious Diseases (NIAID). The company has received a significant Phase II SBIR contract valued at $1,498,641 for developing a CRISPR-based diagnostic test for parasites, with a completion date of September 14, 2028. This contract is set aside for small businesses and represents the company's continued work in advanced diagnostic technology development. The contract is a Firm Fixed Price agreement focused on creating innovative diagnostic solutions that can potentially transform parasitic disease detection methods.
On the federal grant side, Biological Mimetics, Inc. has been awarded multiple project grants from NIAID focusing on vaccine development and diagnostic technologies. These grants include a project to develop a novel vaccine candidate against multi-drug resistant Acinetobacter baumannii, a vaccine development project for Staphylococcus aureus, and a grant to create an instrument-free malaria diagnostic test. Additionally, the company received a grant from the Institute of Food Production and Sustainability to develop an improved PCV2 vaccine for the pork industry. These grants, ranging from approximately $288,360 to $300,000, demonstrate the company's broad capabilities in developing innovative solutions for infectious diseases, animal health, and diagnostic technologies across multiple domains.
SBA capabilities narrative
BMI offers scientific services and biomedical reagents. Services include gene expression, virology, immunology, molecular biology, and vaccine design and development.
Quick answers
Is Biological Mimetics, Inc. registered in SAM.gov?
Yes. Biological Mimetics, Inc.'s SAM.gov registration is active through May 7, 2027.
What is Biological Mimetics, Inc.'s CAGE code?
Biological Mimetics, Inc.'s CAGE code is 3FN24, and its Unique Entity ID (UEI) is LJARDLY9MMK5.
How much has Biological Mimetics, Inc. received in federal contracts?
Federal contracts obligated $1,498,641 to Biological Mimetics, Inc. in fiscal year 2025 and $1,798,458 in fiscal years 2023 through 2027.
What is Biological Mimetics, Inc.'s most recent federal award?
Biological Mimetics, Inc.'s most recent federal contract award is Phase II sbir biological mimetics, INC. Award (75N93025C00031), from National Institute of Allergy and Infectious Diseases (NIH), on September 15, 2025.
On GovTribe
See Biological Mimetics, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors